Scam, kidnap by South African police

Scam, kidnap by South African police

Medical Writing Institute click here

MJoTAtalks click here

Emerald Pademelon Press LLC click here

Peace Scientists click here

Dr Susanna loves the countries and the peoples of Africa

Scam, kidnap by South African police

Scam, kidnap by South African police

Bookmark and Share
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes

Latest Top (15) News

"MyPlan" - Pilot Structured Eating Trial for Adolescents With Type 1 Diabetes
Condition:   Type 1 Diabetes
Intervention:   Behavioral: "MyPlan" - Individualized Structured Eating Plan
Sponsors:   University of North Carolina, Chapel Hill;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of Cincinnati

Tue, 07 Dec 2021 12:00:00 EST

A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets in Type 2 Diabetes Mellitus Patients
Condition:   Type 2 Diabetes Mellitus
Intervention:   Drug: DBPR108 tablets
Sponsor:   CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Not yet recruiting

Tue, 07 Dec 2021 12:00:00 EST

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HR011408 at Two Formulations in Healthy Subject
Condition:   Diabetes in Adults
Intervention:   Drug: HR011408 injection
Sponsor:   Jiangsu HengRui Medicine Co., Ltd.
Not yet recruiting

Tue, 07 Dec 2021 12:00:00 EST

Intraoperative Hypotension Predicted by Mean Arterial Pressure
Conditions:   Wedge Resection;   Lobectomy by Video-thoracoscopies
Intervention:   Other: Data collected
Sponsor:   Hospices Civils de Lyon

Tue, 07 Dec 2021 12:00:00 EST

Precision Medicine for Preventing Type 2 Diabetes: a Step Forward
Condition:   PreDiabetes
Interventions:   Other: Digital Health;   Other: Standard care
Sponsors:   University of Pisa;   University of Florence;   Azienda Ospedaliero, Universitaria Pisana
Not yet recruiting

Tue, 07 Dec 2021 12:00:00 EST

Risk Factors for Acute Kidney Injury in Diabetic Patients
Condition:   Diabete Mellitus
Intervention:   Other: CBC ,renal function tests , fundus Examination
Sponsor:   Assiut University
Not yet recruiting

Tue, 07 Dec 2021 12:00:00 EST

Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for Eye Diseases
Conditions:   Eye Diseases;   Retinitis Pigmentosa;   Glaucoma;   Diabetic Retinopathy;   Macular Degeneration;   Traumatic Optic Neuropathy;   Optic Atrophy
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine

Tue, 07 Dec 2021 12:00:00 EST

Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
Conditions:   Diabetes Mellitus, Type 2;   Atherosclerosis
Intervention:   Drug: Semaglutide Oral Tablet
Sponsors:   University Medical Centre Ljubljana;   University of Palermo
Not yet recruiting

Tue, 07 Dec 2021 12:00:00 EST

The Effect of Exercise on Quality of Life, Sleep Quality and Anxiety in Patients With Prediabetes (EFEXQULS)
Conditions:   PreDiabetes;   Physical Inactivity;   Quality of Life;   Sleep;   Anxiety;   Depression
Intervention:   Behavioral: Exercise
Sponsor:   Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey
Not yet recruiting

Tue, 07 Dec 2021 12:00:00 EST

The Effect of Hypoxia on Type 2 Diabetes and Weight Loss
Condition:   Type2 Diabetes
Intervention:   Other: Sleeping in a tent
Sponsors:   University of Portsmouth;   Bournemouth University;   University College, London;   University of Cambridge;   Portsmouth Hospitals NHS Trust
Not yet recruiting

Tue, 07 Dec 2021 12:00:00 EST

The Effects of TMZ on Diabetic Nephropathy
Condition:   Diabetic Nephropathies
Intervention:   Drug: Trimetazidine
Sponsor:   Tongji Hospital
Not yet recruiting

Tue, 07 Dec 2021 12:00:00 EST

A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer
Condition:   Diabetic Foot Ulcer
Interventions:   Drug: Standardized Western Medicine Treatment;   Drug: Tangningtongluo tablet and cream;   Drug: Tangningtongluo tablet;   Drug: Tangningtongluo cream
Sponsor:   Affiliated Hospital of Nantong University
Not yet recruiting

Mon, 06 Dec 2021 12:00:00 EST

A Non-significant Risk Clinical Study of Therapeutic Ultrasound for Patients With Diabetic Foot Ulcers.
Conditions:   Diabetic Foot Ulcer;   Peripheral Arterial Disease;   Wound; Foot
Intervention:   Device: VibratoSleeve Therapeutic Ultrasound Device
Sponsors:   Vibrato Medical, Inc.;   Vascular and Interventional Specialists of Orange County, Inc. (VISOC);   National Institutes of Health (NIH)
Not yet recruiting

Mon, 06 Dec 2021 12:00:00 EST

A Research Study Looking at How Well a Combination of the Medicines Semaglutide and NNC0480-0389 Works in People With Type 2 Diabetes
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: NNC0480-0389;   Drug: Semaglutide;   Drug: Placebo (NNC080-0389);   Drug: Placebo (semaglutide)
Sponsor:   Novo Nordisk A/S

Mon, 06 Dec 2021 12:00:00 EST

Associations of Plasma Fatty Acid Patterns With Gestational Diabetes Mellitus
Condition:   Gestational Diabetes
Intervention:   Other: Plasma fatty acid concentration
Sponsor:   Liegang Liu

Mon, 06 Dec 2021 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News

Coronavirus (COVID-19) Update: December 7, 2021
Coronavirus (COVID-19) Update: December 7, 2021

Tue, 07 Dec 2021 15:36:04 EST

FDA In Brief: FDA Takes New Steps Aimed at Advancing Development of Individualized Medicines to Treat Genetic Diseases
Today, the FDA issued guidances focused on the development of treatments to target genetic diseases, based on an individual patient’s genes. These draft guidances, once finalized, are aimed at helping treatments reach patients in a timely manner.

Tue, 07 Dec 2021 14:31:32 EST

FDA Expands Authorization of Two Monoclonal Antibodies for Treatment and Post-Exposure Prevention of COVID-19 to Younger Pediatric Patients, Including Newborns
FDA revised the EUA of bamlanivimab and etesevimab, administered together, to treat mild to moderate COVID-19 in all younger pediatric patients, including newborns. The drug combination is also now authorized for post-exposure prevention of COVID-19 in all pediatric patients, including newborns.

Fri, 03 Dec 2021 14:23:57 EST

FDA Proposes Changes to Food Safety Modernization Act Rule to Enhance Safety of Agricultural Water Used on Produce
The FDA issued a proposed rule that aims to enhance the safety of produce and if finalized would require certain farms to evaluate potential contamination risks for the water used on crops before harvest and take additional mitigation measures to help protect public health.

Thu, 02 Dec 2021 11:34:14 EST

Coronavirus (COVID-19) Update: November 30, 2021
Coronavirus (COVID-19) Update: November 30, 2021

Tue, 30 Nov 2021 15:39:08 EST

Coronavirus (COVID-19) Update: FDA Actively Working to Investigate, Address Potential Impacts of Omicron Variant; Urges Vaccination and Boosters
FDA is working with federal partners, international regulators and medical product companies to quickly address any potential impacts of the omicron variant.

Tue, 30 Nov 2021 10:13:37 EST

FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions
The FDA today approved Cytalux, an imaging drug intended to assist surgeons in identifying ovarian cancer lesions. The drug is designed to improve the ability to locate additional ovarian cancerous tissue that is normally difficult to detect during surgery.

Mon, 29 Nov 2021 10:52:01 EST

FDA Approves First Treatment for Common Type of Post-Transplant Infection that is Resistant to Other Drugs
The FDA approved the first drug for treating adults and pediatric patients with post-transplant cytomegalovirus infection/disease that does not respond (with or without genetic mutations that cause resistance) to available antiviral treatment for cytomegalovirus.

Tue, 23 Nov 2021 16:36:53 EST

Coronavirus (COVID-19) Update: November 23, 2021
Coronavirus (COVID-19) Update: November 23, 2021

Tue, 23 Nov 2021 15:11:51 EST

FDA Approves First Drug to Improve Growth in Children with Most Common Form of Dwarfism
The FDA approved a drug to improve growth in children five years of age and older with achondroplasia and open growth plates, meaning these children still have the potential to grow. Achondroplasia is the most common form of dwarfism.

Fri, 19 Nov 2021 12:34:36 EST
Diabetes news from the American Diabetes Association

Latest Top (5) News